Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

“These microfluidic chips integrated with organoid models to form complex systems could improve the ability to study tumor progression, drug response and metastasis in a more systematic and controlled ...

The organoid's ... Molecular Zip Code Draws ... Brain Metastases in Patients With HER2-Positive Breast Cancer Sep. 13, 2024 — A drug that delivers chemotherapy directly to tumors has shown ...

Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...

But, Holmen says, this treatment doesn't work as well once the tumor has spread to the brain. There are also targeted drug therapies that people take orally as a pill. "Patients can become ...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug ...

A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...

shows promising preclinical activity in an expanded range of MSLN-positive tumor models including patient derived organoid and/or xenograft models of ovarian, pancreatic, and non-small cell lung ...